Metrex CaviWipes 2.0 (12/Case)

Yes, Metrex CaviWipes 2.0 offer a comprehensive, broad-spectrum efficacy against a wide range of pathogens, achieving universal effectiveness in just two minutes.

These disinfecting wipes are effective against:

• Over 40 pathogens
• All virus types (enveloped, large, and small non-enveloped)
• Bacteria and Fungi

They meet important medical compliance standards, including efficacy claims for:

• Tuberculocidal, Bactericidal, Virucidal, and Fungicidal activity.
• Effectiveness against SARS-CoV-2 (compliant with EPA List N).
• Meeting OSHA’s Bloodborne Pathogen Guidelines.

Yes, Metrex CaviWipes 2.0 are highly effective and compliant with the latest standards for viral control.

Key compliance points include:

• EPA List N Compliant: The wipes are proven effective against SARS-CoV-2.
• Emerging Viral Pathogen Claim: They qualify for the EPA’s rigorous Emerging Viral Pathogen Claim, ensuring readiness against current and future outbreaks.
• Broad-Spectrum Efficacy: These wipes are effective against all virus types (enveloped, large and small non-enveloped) and over 40 pathogens in total, achieving universal efficacy in a rapid two-minute contact time.

The Metrex CaviWipes 2.0 are packaged for high-volume use, providing a total of 1,920 disinfecting towelettes per case.

The case configuration includes:

• 12 canisters
• 160 towelettes per individual canister

Metrex CaviWipes 2.0 are high-performance, one-step disinfecting towelettes designed for demanding environments where high-level surface disinfection is required. They are ideal for use in:

• Hospitals and Clinics
• Schools
• Care Centers

These wipes are formulated to be compatible and effective on most hard, non-porous surfaces, fulfilling both cleaning and disinfection requirements in a single step.

The Metrex CaviWipes 2.0 feature a rapid, universal contact time of just two minutes. This short dwell time is effective against a broad spectrum of microbes, including:

• Bacteria
• Fungi
• Tuberculocidal organisms
• Viruses (including SARS-CoV-2, which is EPA List N compliant)

This rapid efficacy ensures quick disinfection and optimizes efficiency in high-demand clinical environments.

Yes, Metrex CaviWipes 2.0 are formulated for use on most hard, non-porous surfaces.

These high-performance wipes are a 1-Step Germicide, making them ideal for high-level disinfection in demanding clinical and institutional settings, such as:

• Hospitals and clinics
• Schools
• Care centers

They are effective on surfaces like countertops and medical equipment, meeting OSHA’s Bloodborne Pathogen Guidelines.

CaviWipes 2.0 are effective against Mycobacterium tuberculosis (TB).

No, CaviWipes 2.0 are designed for use on hard, non-porous surfaces only.

Yes, Metrex CaviWipes 2.0 are formulated for broad-spectrum efficacy and are proven effective against over 40 different pathogens.

Key aspects of their comprehensive coverage include:

• Pathogen Types: Effective against all virus types (enveloped, large and small non-enveloped viruses), bacteria, and fungi. They are also tuberculocidal.
• Rapid Action: They achieve universal contact time efficacy against bacteria, fungi, and most pathogens in just two minutes.
• Emerging Threat Ready: CaviWipes 2.0 qualifies for the EPA’s rigorous Emerging Viral Pathogen Claim and is compliant with EPA List N, confirming efficacy against SARS-CoV-2.
• OSHA Compliant: They meet OSHA’s Bloodborne Pathogen Guidelines as a 1-Step Germicide, making them suitable for high-level disinfection in demanding clinical environments.

The Metrex CaviWipes 2.0 are sold in a bulk case configuration, providing a total of 1,920 towelettes.

Here is the breakdown of the contents per case:

• Canisters: 12
• Wipes per canister: 160